AtriCure, Inc. (ATRC)
Data as of Nov 3, 11:20 AM ETPrices may be delayedHow our data works
Res / Sup are automatic swing levels for educational reference only — not signals or advice.
Prices may be delayed. For informational purposes only — not investment advice.
ATRC key stats
ATRC GlowScore: Active
A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.
About AtriCure, Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
What's moving ATRC today
Updated November 3, 2026As of November 3, 2026, AtriCure, Inc. (ATRC) stock rose to $61.05, up 1.95% (+$1.17) versus the previous close. On the day, shares have traded between $59.09 and $61.54. That puts ATRC near the top of its 52-week range of $25.36 to $63.00. AtriCure, Inc. operates in the surgical & medical instruments & apparatus space and carries a market capitalization of roughly $3.05 billion, with about 182.2K shares changing hands.
Latest ATRC news
- AtriCure to Participate at Upcoming Investor ConferencesYahoo Finance· Oct 26, 8:00 AM ETLAA
- AtriCure to Announce Third Quarter 2026 Financial ResultsYahoo Finance· Oct 13, 8:00 AM ETLAA
- AtriCure (ATRC) Stock Gets Fair Value Bump As Analysts Weigh Procedure Growth And RisksYahoo Finance· Oct 4, 8:19 PM ET
- AtriCure (ATRC) Stock Looks Rich Against Its Sales BaseYahoo Finance· Sep 25, 7:07 PM ET
- Why AtriCure (ATRC) Is Back In The SpotlightYahoo Finance· Sep 25, 1:14 PM ET
- AXT Inc. (AXTI) Climbs 16% on S&P 600 AdditionYahoo Finance· Sep 21, 4:00 PM ETAXTI
- Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?Yahoo Finance· Sep 14, 9:40 AM ETAVAH
- AtriCure CTO Sells 3,657 Sharesfool.com· Sep 12, 8:05 PM ET
Source: Yahoo Finance RSS · Updated November 3, 2026
Want ATRC headlines, alerts and AI research in one place? Create a free account →
ATRC buzz on Stocktwits
414 watchers$ATRC reports after the close, Estimize Consensus +0.05 EPS and +1.10M Revs compared to WS http://www.estimize.com/atrc/fq3-2026?utm_conten
@Estimize· Nov 3, 11:00 AM ET
@Jblack500 @WAJeff @cynicaloptimist @Cash4freedom @SonGoku Yo $ATRC - been waving at ya @howardlindzon
@MaverikIT· Nov 2, 8:54 AM ET
$ATRC undiscovered breakout with 410 watchers
@STRelativeStrength· Oct 27, 2:20 PM ET
$ATRC Setting up nicely for new highs. Breakout watch over 61.7
@ACInvestorBlog· Oct 26, 5:19 PM ET
$ATRC Breaking out of high tight flag
@Albino_Trader123· Oct 26, 11:17 AM ET
Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →
ATRC Congress & insider trades
Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.
AI research on ATRC
Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.
Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.